HOOK Novinky na Forexu
Hookipa Pharma Says Gilead Purchases Addl. 15 Mln Shares Of HOOKIPA For Total Stake Of About 19.4%
Immunotherapeutics company Hookipa Pharma Inc. (HOOK) announced Thursday that Gilead Sciences, Inc. (GILD) has purchased 15 million shares of HOOKIPA's common stock for approximately $21.25 million, at a price of $1.4167 per share.
RTTNews
|
Před 303 dny
HOOKIPA Pharma Promotes Katia Schlienger As Chief Medical Officer
Biopharmaceutical company HOOKIPA Pharma Inc. (HOOK) announced Thursday the promotion of Katia Schlienger, to Chief Medical Officer and the appointment of Malte Peters, to its Board of Directors, both effective January 1, 2023.
RTTNews
|
Před 674 dny
